The headlines following a 23 September hearing featuring US Food & Drug Administration Commissioner Stephen Hahn certainly are not the type of thing that breeds confidence.
Just hours after Hahn testified about FDA’s commitment to rigorous scientific standards in the review of potential COVID-19 vaccine candidates, President Trump undercut the message with the suggestion that the White House might reject the agency’s own unpublished guidance for sponsors seeking an Emergency Use Authorization for a vaccine